Details for Patent: 5,898,032
✉ Email this page to a colleague
Summary for Patent: 5,898,032
Title: | Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy |
Abstract: | A method of female contraception involves administering a combination of estrogen and progestin for 60-110 consecutive days in which the daily amounts of estrogen and progestin are equivalent to about 5-35 mcg of ethinyl estradiol and about 0.025 to 10 mg of norethindrone acetate, respectively. The advantages include less menstrual bleeding, less patient anemia, less total exposure to medication, higher compliance rates and more lifestyle convenience for patients. |
Inventor(s): | Hodgen; Gary D. (Virginia Beach, VA) |
Assignee: | Medical College of Hampton Roads (Norfolk, VA) |
Application Number: | 08/880,419 |
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 5,898,032
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 5,898,032
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 216241 | ⤷ Try a Trial | |||
Canada | 2256977 | ⤷ Try a Trial | |||
Canada | 2596416 | ⤷ Try a Trial | |||
Germany | 69804918 | ⤷ Try a Trial | |||
Denmark | 0911029 | ⤷ Try a Trial | |||
European Patent Office | 0911029 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |